BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a protein naturally found in human gastric juice. It is widely studied in preclinical research for its role in tissue repair, angiogenesis, and cytoprotective signalling.

How do I reconstitute BPC-157?

Reconstitute with 1-2 ml of bacteriostatic water. Allow the vial to reach room temperature, inject solvent gently down the inside wall, and swirl gently. Never shake. Store reconstituted solution at 2-8°C and use within 4-6 weeks.

What purity is BioLab's BPC-157?

Every batch is independently tested via HPLC and mass spectrometry to confirm 99%+ purity and correct molecular identity. A batch-specific Certificate of Analysis is available with every order.

How should I store BPC-157?

Store lyophilised vials at -20°C, protected from light and moisture. Once reconstituted with bacteriostatic water, store at 2-8°C and use within 4-6 weeks. Avoid repeated freeze-thaw cycles.

AOD-9604 5mg fat loss peptide | buy AOD-9604 UK at BioLab Peptides

Fragment AOD-9604 5 mg

£25.00

AOD-9604 (Advanced Obesity Drug) is a modified fragment of human growth hormone (amino acids 177-191) with an added tyrosine at the N-terminus. Studied for lipolytic activity without affecting IGF-1 levels or glucose homeostasis. Available to buy in the UK, 5 mg, 99%+ purity.

Purity: ≥99% (HPLC & MS)
Quantity: 5 mg per vial
CAS: 221231-10-3
Structure: Modified HGH fragment 177-191 + Tyr
Storage: -20°C · 2–8°C reconstituted

Categories: All Peptides, Growth Hormone Secretagogues, Weight Management

Description
Reviews (0)

AOD-9604 5 mg | Lipolysis Research Peptide

AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment of human growth hormone (amino acids 177-191), modified with an N-terminal tyrosine residue. This modification was designed to isolate the lipolytic (fat-metabolising) activity of GH from its growth-promoting (IGF-1-elevating) effects — making AOD-9604 a targeted tool for lipid metabolism research.

Research Background

Lipolytic activity without IGF-1 elevation — AOD-9604 has been studied for its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation) in adipose tissue models without increasing IGF-1 levels — a significant distinction from full-length GH.

Beta-3 adrenergic receptor interaction — Some research suggests AOD-9604 may influence fat metabolism through beta-3 adrenergic receptor pathways, adding mechanistic depth beyond simple GH-fragment activity.

Cartilage and bone research — Interestingly, AOD-9604 has also been investigated for effects on chondrocyte proliferation and cartilage repair, suggesting biological activity beyond lipid metabolism.